Fibrocor Therapeutics
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
661 University Ave Ste 465, Toronto, Ont...Phone Number
(647) 978-3697Website
www.fibrocortherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Fibrocor Therapeutics
Fibrocor is a privately held, tissue specific, drug discovery company. It is pioneering the use of tissue specific therapeutics in the field of precision medicine and in particular, Fibrosis. The company has partnered with leading research institutes in Toronto, Canada, to aggregate and interrogate diseased fibrotic tissue samples in a number of organ systems to understand the genesis of the disease and its manifestations in fast progressing populations.Explore more
Fibrocor Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fibrocor Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Fibrocor Therapeutics has new funding data
Product Launch: Get notified when Fibrocor Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Fibrocor Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Fibrocor Therapeutics recently announced quarterly report
Check out if Fibrocor Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Fibrocor Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Fibrocor Therapeutics
Click to see if Fibrocor Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Fibrocor Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Fibrocor Therapeutics
Compare insights from companies similar to Fibrocor Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Fibrocor Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Fibrocor Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Fibrocor Therapeutics.
Fibrocor Therapeutics Tech Stack
A closer look at the technologies used by Fibrocor Therapeutics
See more technologies
Fibrocor Therapeutics News & Media
Fibrocor and Galapagos sign expanded collaboration in fibrosis
Mechelen, Belgium and Toronto, Canada; 15 January 2020, 7.30 CET – Galapagos NV (Euronext & NASDAQ: GLPG) and Fibrocor Therapeutics Inc....Fibrocor and Galapagos sign partnership in fibrosis
Mechelen, Belgium; 4 January 2019, 22.01 CET - Fibrocor Therapeutics L.P. (Fibrocor), a privately held Canadian company, and Galapagos NV (Euronext & NASDAQ: GLPG) announced a global partnership focused on a novel target for idiopathic pulmonary fibrosis (IPF) and other indications.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Fibrocor Therapeutics
Sign Up For FreeTo access detailed company insights
Fibrocor is a privately held, tissue specific, drug discovery company. It is pioneering the use of tissue specific therapeutics in the field of precision medicine and in particular, Fibrosis. The company has partnered with leading research institutes in Toronto, Canada, to aggregate and interrogate diseased fibrotic tissue samples in a number of or... Read More
